| 27.16 -1.46 (-5.1%) | 11-06 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 34.91 | 1-year : | 40.77 |
| Resists | First : | 29.88 | Second : | 34.91 |
| Pivot price | 22.2  |
|||
| Supports | First : | 21.73 | Second : | 16.7 |
| MAs | MA(5) : | 24.34 |
MA(20) : | 21.39 |
| MA(100) : | 22.7 |
MA(250) : | 23.98  |
|
| MACD | MACD : | 1.5 |
Signal : | 0.7 |
| %K %D | K(14,3) : | 86.2 |
D(3) : | 78.8 |
| RSI | RSI(14): 69.2 |
|||
| 52-week | High : | 32.4 | Low : | 16.7 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ ENOV ] has closed below upper band by 0.4%. Bollinger Bands are 71.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 27.69 - 27.83 | 27.83 - 27.92 |
| Low: | 26.29 - 26.47 | 26.47 - 26.59 |
| Close: | 26.89 - 27.17 | 27.17 - 27.35 |
Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries. The company's extensive product line encompasses rigid and flexible orthopedic supports, thermal and cryotherapy items, bone growth stimulation devices, vascular therapy systems paired with compression garments, therapeutic footwear and orthotics, electrical stimulators for pain alleviation, and physical rehabilitation equipment. Additionally, Enovis provides a comprehensive array of reconstructive joint implants for areas such as the hip, knee, shoulder, elbow, foot, ankle, and fingers. Enovis Corporation distributes its products through a network of independent channels, including healthcare providers, retail establishments, and pharmacies, in addition to direct sales under its prominent DJO brand. Previously known as Colfax Corporation, the company is headquartered in Wilmington, Delaware.
Sat, 07 Nov 2026
What Enovis (ENOV) Said on Its Q3 Earnings Call - TradingView
Fri, 06 Nov 2026
Enovis Corporation 2026 Q3 - Results - Earnings Call Presentation (NYSE:ENOV) 2026-11-06 - Seeking Alpha
Thu, 05 Nov 2026
Enovis Corp (ENOV) Q3 2026 Earnings Call Highlights: Organic Growth of 5%, Raised Guidance, and ... - Yahoo Finance
Thu, 05 Nov 2026
Enovis Corporation Q3 2026 Earnings Call Summary - Yahoo Finance
Thu, 05 Nov 2026
Enovis Corporation (ENOV) Tops Q3 EPS by 11c ; Offers Guidance - StreetInsider
Thu, 05 Nov 2026
Why are Enovis (ENOV) shares soaring today - FinancialContent
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 58 (M) |
| Shares Float | 53 (M) |
| Held by Insiders | 1.6 (%) |
| Held by Institutions | 120.3 (%) |
| Shares Short | 10,560 (K) |
| Shares Short P.Month | 9,090 (K) |
| EPS | -19.23 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 25.61 |
| Profit Margin | -48 % |
| Operating Margin | 4.1 % |
| Return on Assets (ttm) | 1.2 % |
| Return on Equity (ttm) | -54.2 % |
| Qtrly Rev. Growth | 3.2 % |
| Gross Profit (p.s.) | 24.44 |
| Sales Per Share | 39.88 |
| EBITDA (p.s.) | 6.58 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 270 (M) |
| Levered Free Cash Flow | 186 (M) |
| PE Ratio | -1.42 |
| PEG Ratio | 3.4 |
| Price to Book value | 1.06 |
| Price to Sales | 0.68 |
| Price to Cash Flow | 5.79 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|